Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.
about
The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema.Are payers treating orphan drugs differently?Hereditary angioedema: imaging manifestations and clinical management.Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors.Hereditary Angioedema: The Economics of Treatment of an Orphan Disease.
P2860
Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Management of hereditary angio ...... pharmacoeconomic perspectives.
@ast
Management of hereditary angio ...... pharmacoeconomic perspectives.
@en
type
label
Management of hereditary angio ...... pharmacoeconomic perspectives.
@ast
Management of hereditary angio ...... pharmacoeconomic perspectives.
@en
prefLabel
Management of hereditary angio ...... pharmacoeconomic perspectives.
@ast
Management of hereditary angio ...... pharmacoeconomic perspectives.
@en
P2860
P1476
Management of hereditary angio ...... pharmacoeconomic perspectives.
@en
P2093
Joshua P Cohen
Stephen A Tilles
P2860
P356
10.1016/J.ANAI.2012.11.014
P577
2012-12-17T00:00:00Z